AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 DEC 12 - (NewsRx.com & NewsRx.net) -- An experimental method has been developed to tackle metastasized kidney cancer, according to a report by the Netherlands Organization for Scientific Research.
After being engineered outside the body, T cells taken from the body's own immune system attack the cancer. Clinical studies in the next few years will show whether the medication also works in actual practice.
The experimental method is based on genetically engineered T cells. The researchers, at Rotterdam University Hospital's Daniel den Hoed Cancer Center, take T cells from the immune system and alter them outside the body. The adapted T cells then find the metastasized kidney cancer cells in the body. When they have found their target, the standard machinery of the immune system takes over. The body attacks the cancer cells and wipes them out.
The genetically engineered T cells do their job very effectively during in vitro experiments. Over the next few years, the researchers intend carrying out extensive clinical studies.
The immunologists carry out tests on the tumor in each patient because there ...
Source: HighBeam Research, Genetically Engineered T Cell Tackles Tumors.(Brief Article)